Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Angel & family office | 1 | 33% |
| Accelerator & incubator | 1 | 33% |
Canadian, early-stage biotech developing chitosan-based nanotech drug delivery for Oncology, Neurodegenerative, and DR Infections
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Angel & family office | 1 | 33% |
| Accelerator & incubator | 1 | 33% |